Skip to main content
Log in

Management of unresponsive asthma

  • Symposium on Pulmonology
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Difficult asthma is defined as asthma that is not controlled despite treatment with <>800 ug budesonide or equivalent per day. Poor control is defined as the need for bronchodilators more than three times a week, school absence of more than five days a term, or one episode or more of wheezing each month. Common causes of poor response to treatment include; wrong diagnosis, inappropriate medications or improper inhalation technique, poor adherence to medications and co-morbidity. Steroid resistant asthma is uncommon and estimated to be 1 in 1000–10000 asthmatic patients. If there is no functional improvement to prednisolone 2 mg/kg/day for 2 weeks with adherence checked by measuring serum prednisoloneand cortisol levels, a fibreoptic bronchoscopic examination with bronchoalveolar lavage and large airway biopsy should be considered. Eosinophilic inflammation identified on the biopsy in a child who is unresponsive to prednisolone may benefit from alternative anti-inflammatory treatments such as cyclosporin. Neutrophilic infiltration in biopsy may benefitwith macrolide antibiotics, 5-lipogenase inhibitors or theophyllines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lodha R, Puranik M, Kattal N, Kabra SK. Social and Economic Impact of Childhood Asthma.Indian Pediatr 2003; 40: 874–879.

    PubMed  Google Scholar 

  2. Singh M, Kumar L, Ramanathan RMLP. Consensus guidelines on management of childhood asthma in India.Indian Pediatr 1999; 36: 157–165.

    Google Scholar 

  3. National Heart Lung and Blood Institute and World Health Organization. Global initiative for asthma. National Institute of Health, Bethesda. 1995 Publication No. 95-3659.

  4. National Heart Lung and Blood Institute. Expert panel report 2. Guideline for the diagnosis and management of asthma. National Institute of Health, Bethesda HD, 1997 Publication No. 97-4051.

  5. The British guideline on asthma management review and position statement.Thorax 1997; 52: S1-S21.

  6. Chung KF, Godard P, Adelroth Eet al. Difficult/therapyresistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.Eur Respir J 1999; 13: 1198–208.

    PubMed  CAS  Google Scholar 

  7. Holt S, Suder A, Weatherall Met al. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis.BMJ 2001; 323: 253.

    Article  PubMed  CAS  Google Scholar 

  8. Silverman M. Childhood asthma and other wheezing disorders. London: Chapman and Hall, 1995.

    Google Scholar 

  9. Keeley D, Osman L. Dysfunctional breathing and asthma. It is important to tell the difference.BMJ 2001; 322: 1075–1076.

    Article  PubMed  CAS  Google Scholar 

  10. Fox GF, Everard ML, Marsh MJet al. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing.Arch Dis Child 1999; 80: 343–347.

    PubMed  CAS  Google Scholar 

  11. Chavasse RJ, Bastian-Lee Y, Richter Het al. Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone.Arch Dis Child 2001; 85: 143–148.

    Article  PubMed  CAS  Google Scholar 

  12. Warner JO. Review of prescribed treatment for children with asthma in 1990.BMJ 1995; 311: 663–666.

    PubMed  CAS  Google Scholar 

  13. Gibson NA, Ferguson AE, Aitchison TCet al. Compliance with inhaled asthma medication in preschool children.Thorax 1995; 50: 1274–1279.

    PubMed  CAS  Google Scholar 

  14. Jonasson G, Carlsen KH, Blomqvist P. Clinical efficacy of lowdose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids.Eur Respir J 1998; 12: 1099–1104.

    Article  PubMed  CAS  Google Scholar 

  15. Wilson RG. Fabricated or induced illness in children. Munchausen by proxy comes of age.BMJ 2001; 323: 296–297.

    Article  PubMed  CAS  Google Scholar 

  16. Harding SM: Gastro-oesophageal reflux and asthma: Insight into the association.J Allergy Clin Immunol 1999; 104: 251–259.

    Article  PubMed  CAS  Google Scholar 

  17. Thomas EJ, Kumar R, Dasan JB, Kabra SK, Bal CS, Menon S, Malhothra A. Gastroesophageal reflux in asthmatic children not responding to asthma medication. A scintigraphic study in 126 patients with correlation between scintigraphic and clinical findings of reflux.Clin Imaging 2003; 27: 333–336.

    Article  PubMed  CAS  Google Scholar 

  18. Andze GO, Brandt ML St. Vil Det al. Diagnosis and treatment of gastro-esophageal reflux in 500 children with respiratory symptoms; the value of pH montoring.J Pediatr Surg 1991; 26: 295–299.

    Article  PubMed  CAS  Google Scholar 

  19. Gustafsson PM, Kjellman NI, Tibbing L. Bronchial asthma and acid reflux into the distal and proximal oesophagus.Arch Dis Child 1990; 65: 1255–1258.

    PubMed  CAS  Google Scholar 

  20. Galmiche JP, Brandstatter G, Evreux M, Hentschel E, Kerstan E, Kratochvil Pet al. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.Gut 1988; 29: 675–681

    Article  PubMed  CAS  Google Scholar 

  21. Kelly DA. Do H2 receptor antagonists have a therapeutic role in childhood?J Pediatr Gasroenterol Nutr 1994; 19: 270–276.

    Article  CAS  Google Scholar 

  22. Cucchiara S, Minella R, Iervolino Cet al. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.Arch Dis Child 1993; 69: 655–659

    PubMed  CAS  Google Scholar 

  23. Kato S, Ebina K, Fujii Ket al. Effect of Omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four hour intragastric acidity.J Pediatr 1996; 128: 415–121.

    Article  PubMed  CAS  Google Scholar 

  24. Hassall E, Israel D, Shepherd Ret al. Omeprazole for treatment of chronic erosive oesophagitis in children; a multi center study of efficacy, safety, tolerability and dose requirements.J Pediatr 2000; 137: 800–807.

    Article  PubMed  CAS  Google Scholar 

  25. Tolia V, Ferry G, Gunasekaran T, Huang B, Keith R, Book L. Efficacy of lansoprazole in the treatment of gastro-esophageal reflux disease in children.J Pediatr Gastoenterol Nutr 2002 35; S308-S318.

    CAS  Google Scholar 

  26. Tolia V, Fitzgerald J, Hassall E, Huang B, Pilmer B, Kane R ffl. Safety of Lansoprazole in the treatment of gastro-esophageal reflux disease in children.J Pediatr Gastoenterol Nutr 2002; 35: S300-S307.

    CAS  Google Scholar 

  27. Tsao CH, Chen LC, Yeh KW, Huang JL. Concomitant chronic sinusitis treatment in children with mild asthma: the effect on bronchial hyperresponsiveness.Chest 2003; 123: 757–764.

    Article  PubMed  Google Scholar 

  28. Ranganathan SC, Payne DN, Jaffe Aet al. Difficult asthma: defining the problems.Pediatr Pulmonol 2001; 31: 114–1120.

    Article  PubMed  CAS  Google Scholar 

  29. Sulakvelidze I, Inman MD, Rerecich Tet al. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics.Eur Respir J 1998; 11: 821–827.

    Article  PubMed  CAS  Google Scholar 

  30. Nimmagadda SR, Szefler SJ, Spahn JDet al. Allergen exposure decreases glucocorticoids receptor binding affinity and steroid responsiveness in atopic asthmatics.Am J Respir Crit Care Med 1997; 155: 87–93.

    PubMed  CAS  Google Scholar 

  31. Strachan DP, Carey IM. Home environment and severe asthma in adolescence: a population based case-control study.BMJ 1995; 311: 1053–106.

    PubMed  CAS  Google Scholar 

  32. Custovic A, Woodcock A. On allergens and asthma (again): does exposure to allergens in homes exacerbate asthma?Clin Exp Allergy 2001; 31: 670–673.

    Article  PubMed  CAS  Google Scholar 

  33. Carter MC, Perzanowski MS, Raymond Aet al. Home intervention in the treatment of asthma among inner-city children.JAllergy Clin Immunol 2001; 108: 732–737.

    Article  CAS  Google Scholar 

  34. Ratageri VH, Kabra SK, Dwivedi SN, Seth V. Factors associated with severe asthma.Indian Pediatr 2000; 37: 1072–1082.

    PubMed  CAS  Google Scholar 

  35. Payne DN, Wilson NM, James Aet al. Evidence for different subgroups of difficult asthma in children.Thorax 2001; 56: 345–350.

    Article  PubMed  CAS  Google Scholar 

  36. Payne DNR, Adcock IM. Molecular mechanisms of corticosteroid resistance.Pediatr Respir Rev 2001; 2: 145–150.

    Article  CAS  Google Scholar 

  37. Chapman KR. Asthma unresponsive to usual therapy. In FitzGerald JM, Ernst P, Boulet LP, Cbryne PM, eds.Evidence Based Asthma Management, London, BC Decker Inc, 2001; 291–305.

    Google Scholar 

  38. Payne D, McKenzie SA, Stacey Set al. Safety and ethics of bronchoscopy and endobronchial biopsy in difficult asthma.Arch Dis Child 2001; 84: 423–426

    Article  PubMed  CAS  Google Scholar 

  39. Coren ME, Rosenthal M, Bush A. The use of cyclosporin in corticosteroid dependent asthma.Arch Dis Child 1997; 77: 522–23.

    Article  PubMed  CAS  Google Scholar 

  40. McKenzie SA, Bush A. Difficult asthma in children.Arch Dis Child 2003; 88: 168–169

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. K. Kabra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kabra, S.K., Lodha, R. Management of unresponsive asthma. Indian J Pediatr 71, 729–732 (2004). https://doi.org/10.1007/BF02730664

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02730664

Keywords

Navigation